Archive - December 2018
Kala Pharmaceuticals Announces New Drug Application for KPI-121 0.25% for Dry Eye Disease Has Been Accepted for Review by the U.S. Food and Drug Administration
Sarepta Therapeutics Completes Submission of New Drug Application Seeking Approval of Golodirsen (SRP-4053) in Patients with Duchenne Muscular Dystrophy Amenable to Skipping Exon 53
Your Hot Flashes Are Not Always Caused By Menopause
What Is ‘Selfie Wrist’? Medical Condition Cases Increasing, Doctor Says
What Causes Stomach Ulcers?
Braeburn Announces Tentative FDA Approval of Brixadi (buprenorphine) Extended-Release Injection for the Treatment of Moderate to Severe Opioid Use Disorder
What Your Fingernails Can Indicate About Your Health
5 Health Benefits Of Spinach
